MoreLatest news
August 2008
Amsterdam Molecular Therapeutics Reports Half Year Results 2008
read more
read more
August 2008
AMT to Release Half Year 2008 Results on August 13, 2008
read more
read more
July 2008
AMT Appoints Director Global Marketing and Sales
read more
read more
July 2008
AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
read more
read more
June 2008
AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (Glybera®)
read more
read more
June 2008
AMT makes important advance in the development of its gene therapy for Hemophilia B - Company Accesses Technology to Prevent Immune Response
read more
read more
May 2008
AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
read more
read more
May 2008
AMT Announces Presentations during the 11th Annual Meeting of the ASGT
read more
read more
May 2008
AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity
read more
read more
May 2008
AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
read more
read more
